President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.

Trade flows remain balanced at roughly $48 billion in imports and $49 billion in exports, yet 91% of biologics sold domestically are imported, revealing a paradox: America manufactures heavily but ...

Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital transformation, streamlined operations and strategic partnerships to ...

The South Australian plant is at the centre of debate over whether a $672 million takeover of the entire business can proceed ...

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.

Drug major Sun Pharma on Wednesday said it is open to enhancing its manufacturing footprint in the US amid the Trump ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous communications on the ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Besides the pharmaceutical industry, the Holy Father also criticized the influence of big tech in promoting unhealthy, ...

Clawbacks for the 2024 hospital pharmaceutical budget came in marginally lower than 2023’s critical levels, remaining at an ...